Thyroid nodules are common and are found in up to 68% of patients on US, 25% on CT, and 18% on MRI (1). The prevalence of nodules is higher in females, and it increases with age (1). Nodules are found in 50% of women over 70 years of age, and the female to male ratio is 4 to 1(1). Most nodules are benign and 7–15% are malignant(2). Most malignant nodules are slow-growing and asymptomatic, and do not lead to death if left alone(3). Surgery on these indolent nodules represents overtreatment, increasing patient anxiety and morbidity, while not having a noticeable impact on survival. The increasing utilization of imaging together with refinements in imaging technologies contribute to overdiagnosis of thyroid nodules. Between 2003 and 2007, overdiagnosis was responsible for 70–80% of thyroid cancers in women and 45% in men in the USA(3). The combination of overdiagnosis and overtreatment of thyroid nodules has a profound impact on healthcare economics. In the USA, the estimated total cost of thyroid cancer treatment was $21.6 billion (2010 to 2019) with $4.5 billion attributed to extra costs from increased incidence(1).
The American College of Radiology (ACR) published its Thyroid Imaging Reporting and Data System (TI-RADS) in 2017, an ultrasound-based risk stratification system for thyroid nodule assessment(3). The purpose of TI-RADS was multifactorial: 1) to reduce the number of unnecessary biopsies and excessive surveillance of thyroid nodules, 2) to be able to characterize all nodules, 3) to provide a robust system that can be easily used by all radiologists, irrespective of their level of training or prior experience, and 4) to standardize reporting and provide consistent management recommendations across practices(1, 3, 4, 5). In ACR TI-RADS, nodules are risk stratified according to five sonographic features including consistency, echogenicity, shape, margins, and echogenic foci (Tab. 1). Each feature is assigned points which are tallied to determine the nodule’s overall risk level (known as the TR level) – this ranges from TR1 (benign) to TR 5 (highly suspicious). The combination of the nodule’s TR level and maximal size will determine recommendations for either
Five sonographic categories and their corresponding points for ACR TI-RADS(3)
Composition (choose 1) | Echogenicity (choose 1) | Shape (choose 1) | Margins (choose 1) | Echogenic Foci (choose all that apply) | |||||
---|---|---|---|---|---|---|---|---|---|
Cystic or almost completely cystic | 0 | Anechoic | 0 | Wider than tall | 0 | Smooth | 0 | None or large comettail artifacts | 0 |
Spongiform | 0 | Hyperechoic isoechoic or | 1 | Taller than wide | 3 | Ill-defined | 0 | Macrocalcifications | 1 |
Mixed cystic and solid | 1 | Hypoechoic | 2 | Lobulated or irregular | 2 | Peripheral (rim) calcifications | 2 | ||
Solid or almost completely solid | 2 | Very hypoechoic | 3 | Extra thyroidal extension | 3 | Punctate echogenic foci | 3 |
Criteria for FNA or follow-up ultrasound according to ACR TI-RADS(3)
Add points from all categories to determine TI-RADS level | ||||
---|---|---|---|---|
0 Points | 2 Points | 3 Points | 4 to 6 Points | 7 Points or more |
TR1 | TR2 | TR3 | TR4 | TR5 |
Benign | Not suspicious | Mildly suspicious | Moderately suspicious | Highly suspicious |
No FNA | No FNA | if ≥FNA 2.5 cm | if ≥FNA 1.5 cm | if FNA ≥1 cm |
Follow-up if ≥1.5 cm | Follow-up if ≥1 cm | Follow-up if ≥0.5 cm |
Despite the benefits of ACR-TI-RADS, there is room for improvement. Hoang
Thus, improving the inter-reader agreement is an important issue to address. Herein, we include several educational tips that imaging practitioners may find helpful for enhancing the consistency of thyroid nodule interpretation with ACR TI-RADS.
Unlike macro-calcifications, neither of these sonographic observations are associated with posterior acoustic shadowing. Punctate echogenic foci (PEF) are round and ≤1 mm, while echogenic interfaces have a linear or tram like appearance (Fig. 1). Large echogenic foci >1 mm associated with comet-tail artifacts (+0 points) denote colloids, and are benign. In contrast, echogenic foci ≤1 mm with comet-tail artifacts should be treated as PEF (+3 points)(4). Pertinently, if echogenic foci are found
The background thyroid parenchyma and adjacent neck musculature are used as the reference for determining the echogenicity of thyroid nodules. Compared to the thyroid parenchyma, hyperechoic nodules have higher echogenicity, isoechoic nodules have similar echogenicity, while hypoechoic nodules have lower echogenicity (Fig. 2) (3). Conversely, very hypoechoic nodules have lower echogenicity than the neck musculature(3). To improve the accuracy and consistency of interpretation, these findings should be evaluated on several tissue planes on the still and cine images.
The echogenicity of a mixed cystic and solid nodule should be evaluated based on the appearance of its solid component alone (Fig. 3). An anechoic appearance (+0 points) is therefore not an option, as this feature is synonymous with a cystic consistency. It is also important not to misinterpret debris/blood clot/necrotic tissue in a cyst for viable solid material(4). Doppler US, careful interrogation of the cine clips, and appropriate adjustment of technical parameters (e.g. gain, depth, focal zone, frequency and dynamic range) may help in making this distinction(4).
In this scenario, given the absence of information available in the current literature, we recommend going with the finding that represents >50% volume of the nodule, as this finding is representative of the majority of the nodule (Fig. 4). When it is 50–50, the more conservative option with the lower point score should be selected (i.e. hyper/ isoechoic, +1 point).
This is a judgment call, as this observation represents a continuum and is thus problematic. Tessler
In this scenario, choose solid (+2 points) for composition and iso-or-hyperechoic (+1 point) for echogenicity (Fig. 6)(3).
By definition, a spongiform nodule is one that is composed of >50% of small cystic spaces that are evenly distributed throughout the nodule – this appearance resembles a sponge (Fig. 7)(3). Intermediate nodules that do not meet this criterion but show a <80% solid volume should be described as being of mixed cystic and solid composition. When echogenic foci are found in a spongi-form nodule, these are not considered as PEF and should be ignored(4).
The ACR TI-RADS committee recommends a more conservative selection of wider-than-tall, or alternatively, not taller-than-wide (+0 points) (Fig. 8)(4). It is important to note that the shape of the nodule should usually be assessed on the transverse plane of the thyroid gland(3). The ACR TI-RADS committee notes that it may rarely be appropriate to assess this characteristic in the sagittal plane if the nodule is obliquely oriented in that plane(4).
The nodule size should be measured in three dimensions (
The margins of a nodule represent its interface/border with the adjacent intra- or extra-thyroidal tissue.
Optimal visualization can be achieved by ensuring that the border of the nodule that is closest to the skin surface is perpendicular to the US beam, and that the appropriate gain and focal zones are used on a high-frequency linear transducer(4). A smooth margin (+0 points) is where the entire circumference of the nodule’s outline is regular and sharply marginated(4). If a nodule’s border is not depicted clearly in spite of optimizing technique and US parameters, then it should be categorized as ill-defined (+0 points). If there are protrusions, angulations or lobulations of parts of the nodule into the surrounding tissues, this should classified as lobulated or irregular (+2 points). Extra-thyroidal extension (+3 points) is a feature reserved for cases where there is an obvious and unequivocal invasion into the surrounding tissues such as the neck muscles, trachea, larynx, vasculature or esophagus(4). Lee
ACR-TI-RADS provides a framework for improving the risk stratification of nodules and reduces the need for unnecessary biopsies. However, there are inherent challenges relating to suboptimal inter-reader agreement. Several educational tips are discussed that may help improve the consistency of nodule interpretation with ACR TI-RADS. This would be a topic for more focused reader education and explanation in future iterations of TI-RADS.